| Anthem Biosciences Business Model | Anthem Biosciences IPO Subscription |
| Anthem Biosciences Anchor Book | Anthem Biosciences Peers Comparison |
Anthem Biosciences IPO Description – Anthem Biosciences is a leading Indian Contract Research, Development, and Manufacturing Organization (CRDMO) offering integrated solutions across the drug development lifecycle. With capabilities in both New Chemical Entities (NCE) and New Biological Entities (NBE), Anthem serves over 550 customers across 44+ countries, including the U.S., Europe, and Japan. The company has completed more than 8,000 unique projects, working on molecules with over 675 clients. It reached INR 1,000 crore in revenue within just 14 years of operations (in FY 2021), making it the fastest-growing CRDMO among assessed Indian peers.
In FY 2025, Anthem recorded the highest revenue growth among its Indian and global peers and supported 10 commercialized molecules, including 5 with a collective end-market sales value of USD 11.3 billion in 2024, expected to grow to USD 21.4 billion by 2029. Anthem’s technological strength spans advanced modalities such as ADCs, RNAi, peptides, lipids, and oligonucleotides, with 242 active projects, including 16 in late-phase and 13 in commercial manufacturing.
Promoters of Anthem Biosciences – Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa, and Ishaan Bhardwaj
Table of Contents
Anthem Biosciences IPO Details
| Anthem Biosciences IPO Dates | 14 – 16 July 2025 |
| Anthem Biosciences IPO Price | INR 540 – 570 per share (Employee discount – INR 50 per share) |
| Fresh issue | NIL |
| Offer For Sale | INR 3,395 crore |
| Total IPO size | INR 3,395 crore |
| Minimum bid (lot size) | 26 shares (INR 14,820) |
| Face Value | INR 2 per share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Anthem Biosciences Financial Performance
| FY 2023 | FY 2024 | FY 2025 | |
| Revenue | 1,056.92 | 1,419.37 | 1,844.55 |
| Expenses | 698.50 | 1,005.75 | 1,273.42 |
| Net income | 385.19 | 367.31 | 451.26 |
| Margin (%) | 36.44 | 25.88 | 24.46 |
Anthem Biosciences Offer News
- Anthem Biosciences RHP
- Anthem Biosciences DRHP
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Anthem Biosciences Valuations & Margins
| FY 2023 | FY 2024 | FY 2025 (Pre-Issue) | FY 2025 (Post-Issue) | |
| EPS | 6.75 | 6.48 | 8.07 | 8.07 |
| PE Ratio | – | – | 66.91 – 70.63 | 66.91 – 70.63 |
| FY 2023 | FY 2024 | FY 2025 | |
| RONW (%) | 24.93 | 20.03 | 20.82 |
| NAV | 30.51 | 34.43 | 43.10 |
| ROCE (%) | 28.94 | 25.22 | 27.64 |
| EBITDA (%) | 41.53 | 36.25 | 36.81 |
| Debt/Equity | 0.07 | 0.12 | 0.05 |
Anthem Biosciences IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
| 19 July 2025 | 130 | – | 3,200 |
| 18 July 2025 | 130 | – | 3,200 |
| 17 July 2025 | 150 | – | 3,200 |
| 16 July 2025 | 150 | – | 3,200 |
| 15 July 2025 | 115 | – | 2,300 |
| 14 July 2025 | 100 | – | 1,900 |
| 12 July 2025 | 95 | – | 1,800 |
| 11 July 2025 | 105 | – | 2,000 |
| 10 July 2025 | 95 | – | 1,700 |
| 9 July 2025 | 65 | – | 1,000 |
Anthem Biosciences IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Employee | Total |
|---|---|---|---|---|---|
| Shares Offered | 1,25,43,518 | 94,07,639 | 2,19,51,158 | 1,68,367 | 4,40,70,682 |
| 16 Jul 2025 | 182.65 | 42.35 | 5.64 | 6.59 | 63.86 |
| 15 Jul 2025 | 0.59 | 9.72 | 2.08 | 2.58 | 3.29 |
| 14 Jul 2025 | 0.37 | 1.55 | 0.58 | 0.98 | 0.73 |
1,78,24,999 shares allotted to anchor investors are not included in these calculations.
Anthem Biosciences – Comparison With Listed Peers
| Company | PE ratio | EPS | RONW (%) | NAV | Revenue (Cr.) |
| Anthem Biosciences | 66.91 – 70.63 | 8.04 | 20.82 | 43.10 | 1,844.55 |
| Syngene International | 51.54 | 12.34 | 11.05 | 117.42 | 3,642.40 |
| Sai Life Sciences | 92.18 | 8.61 | 8.8910.96 | 102.12 | 1,694.57 |
Anthem Biosciences IPO Allotment Status
Anthem Biosciences IPO allotment status is now available on the KFin Tech website. Click on this link to get allotment status.
Anthem Biosciences IPO Dates & Listing Performance
| IPO Opening Date | 14 July 2025 |
| IPO Closing Date | 16 July 2025 |
| Finalization of Basis of Allotment | 17 July 2025 |
| Initiation of refunds | 18 July 2025 |
| Transfer of shares to demat accounts | 18 July 2025 |
| Anthem Biosciences IPO Listing Date | 21 July 2025 |
| Opening Price on NSE | INR 723.05 per share (up 26.85%) |
| Closing Price on NSE | INR 730.35 per share (up 28.13%) |
Anthem Biosciences IPO Reviews – Subscribe or Avoid?
Aditya Birla Money – Subscribe
Anand Rathi – Subscribe
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital – Not rated
Ashika Research –
BP Wealth – Subscribe
Capital Market – Neutral
Canara Bank Securities – Subscribe
Choice Broking – Subscribe for long term
Dalal & Broacha –
Elara Capital –
Elite Wealth – Apply
GCL Broking –
Geojit –
GEPL Capital – Subscribe
Hem Securities – Subscribe for listing gain
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –
Jainam Broking – Subscribe for long term
KR Choksey –
LKP Research –
Marwadi Financial – Subscribe
Motilal Oswal –
Mehta Equities – Subscribe for long term
Nirmal Bang – Subscribe
Reliance Securities –
Sushil Finance –
Samco Securities – Subscribe for long term
SBI Securities – Subscribe for long term
SMC Global – 2/5
SMIFS – Subscribe
Systematix Research –
Swastika Investmart –
Ventura Securities – Subscribe
Anthem Biosciences Offer Lead Manager
JM FINANCIAL LIMITED
7th Floor, Cnergy, Appasaheb Marathe Marg,
Prabhadevi, Mumbai 400 025,
Maharashtra, India
Phone: +91 22 6630 3030
Email: [email protected]
Website: www.jmfl.com
Anthem Biosciences Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
Anthem Biosciences Contact Details
ANTHEM BIOSCIENCES LIMITED
No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area,
Phase 1, Bommasandra, Bangalore, Karnataka, India, 560 099
Phone: +91 080 6672 4000
Email: [email protected]
Website: www.anthembio.com
Anthem Biosciences IPO FAQs
How many shares in the Anthem Biosciences IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply for the Anthem Biosciences Public Offer?
The best way to apply for the Anthem Biosciences public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stockbroker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Anthem Biosciences IPO GMP today?
Anthem Biosciences IPO GMP today is INR 130 per share.
What is Anthem Biosciences kostak rate today?
Anthem Biosciences’ kostak rate today is INR NA per application.
What is Anthem Biosciences Subject to Sauda rate today?
Anthem Biosciences Subject to Sauda rate today is INR 3,200 per application.